Persistent positivity of Antiphospholipid Antibodies: results from the START2 Registry
Di Stefania Cavazza | 20 Luglio 2026 | 0
Ultima modifica: 3 Agosto 2026
Presented at the ISTH 2026 Congress in Paris and simultaneously published on Thrombosis Research, the results of the START2 observational study describe five hundred patients with persistently positive antiphospholipid antibodies (aPL) followed in major Italian Thrombosis Centers (1).


